Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published:November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like New research explores foot positioning to treat knee osteoarthritis August 13, 2025 An Arm and a Leg: Medical-debt watchdog gets sidelined by the new administration March 12, 2025 Epigenetic switch controls renin production in unexpected cell type September 26, 2024